Novel neutrophil-engineered nanovesicles could transform infectious wound treatment

FHS
July 18, 2024
11:05 am

A recent study has developed nanovesicles (NVs) from activated neutrophils, showcasing their ability to perform molecular debridement and accelerate healing in infectious wounds.

United Therapeutics Corp Patent: Treatment of Pulmonary Hypertension with Prostacyclin-Treated Stem Cells

Share this article According to GlobalData’s company profile on United Therapeutics, Cancer treatment biomarkers was a key innovation area identified from patents. United Therapeutics‘s grant

April 4, 2024

Clovibactin – a game-changing novel antibiotic with no resistance

Researchers reported the discovery of a new antibiotic, clovibactin.

September 6, 2023

Invitae sells reproductive health assets amid liquidity concerns

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medical genetics firm Invitae sold

January 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.